Skip to main content

Ischemic burden, treatment allocation, and outcomes in stable coronary artery disease.

Publication ,  Journal Article
Farzaneh-Far, A; Borges-Neto, S
Published in: Circ Cardiovasc Imaging
November 2011

Duke Scholars

Published In

Circ Cardiovasc Imaging

DOI

EISSN

1942-0080

Publication Date

November 2011

Volume

4

Issue

6

Start / End Page

746 / 753

Location

United States

Related Subject Headings

  • Vasodilator Agents
  • United States
  • Treatment Outcome
  • Survival Analysis
  • Severity of Illness Index
  • Risk Assessment
  • Randomized Controlled Trials as Topic
  • Prognosis
  • Middle Aged
  • Male
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Farzaneh-Far, A., & Borges-Neto, S. (2011). Ischemic burden, treatment allocation, and outcomes in stable coronary artery disease. Circ Cardiovasc Imaging, 4(6), 746–753. https://doi.org/10.1161/CIRCIMAGING.111.970111
Farzaneh-Far, Afshin, and Salvador Borges-Neto. “Ischemic burden, treatment allocation, and outcomes in stable coronary artery disease.Circ Cardiovasc Imaging 4, no. 6 (November 2011): 746–53. https://doi.org/10.1161/CIRCIMAGING.111.970111.
Farzaneh-Far A, Borges-Neto S. Ischemic burden, treatment allocation, and outcomes in stable coronary artery disease. Circ Cardiovasc Imaging. 2011 Nov;4(6):746–53.
Farzaneh-Far, Afshin, and Salvador Borges-Neto. “Ischemic burden, treatment allocation, and outcomes in stable coronary artery disease.Circ Cardiovasc Imaging, vol. 4, no. 6, Nov. 2011, pp. 746–53. Pubmed, doi:10.1161/CIRCIMAGING.111.970111.
Farzaneh-Far A, Borges-Neto S. Ischemic burden, treatment allocation, and outcomes in stable coronary artery disease. Circ Cardiovasc Imaging. 2011 Nov;4(6):746–753.

Published In

Circ Cardiovasc Imaging

DOI

EISSN

1942-0080

Publication Date

November 2011

Volume

4

Issue

6

Start / End Page

746 / 753

Location

United States

Related Subject Headings

  • Vasodilator Agents
  • United States
  • Treatment Outcome
  • Survival Analysis
  • Severity of Illness Index
  • Risk Assessment
  • Randomized Controlled Trials as Topic
  • Prognosis
  • Middle Aged
  • Male